Compounds of formula (I) wherein the symbols have meaning as defined herein, are p38 MAP kinase inhibitors, and are useful pharmaceutically for treating TNFα and IL-1 mediated diseases, such as rheumatoid arthritis, and diseases of bone metabolism, e.g. osteoporosis.
Substituted azoles
申请人:——
公开号:US20020049220A1
公开(公告)日:2002-04-25
1
wherein the symbols have meaning as defined herein, are p38 MAP kinase inhibitors, and are useful pharmaceutically for treating TNF&agr; and IL-
1
mediated diseases, such as rheumatoid arthritis, and diseases of bone metabolism, e.g. osteoporosis.